These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7887367)

  • 1. FDA addresses childhood iron poisoning.
    Am Pharm; 1995 Jan; NS35(1):10. PubMed ID: 7887367
    [No Abstract]   [Full Text] [Related]  

  • 2. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the prevention of childhood iron poisoning.
    Woolf A; Litovitz T
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):593-5. PubMed ID: 15939862
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strike against preemption.
    Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children.
    Tenenbein M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):557-60. PubMed ID: 15939855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Mar; 77(54):16158-63. PubMed ID: 22479732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA industry report on safety packaging.
    Verhulst HL; Crotty JJ
    Bull Natl Clgh Poison Control Cent; 1971; ():1-5. PubMed ID: 5164105
    [No Abstract]   [Full Text] [Related]  

  • 11. Vioxx may go back on sale after scraping past FDA panel.
    Wadman M
    Nature; 2005 Feb; 433(7028):790. PubMed ID: 15729304
    [No Abstract]   [Full Text] [Related]  

  • 12. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 13. Remarks by the Commissioner of Food and Drugs.
    Kessler DA
    Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 15. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
    [No Abstract]   [Full Text] [Related]  

  • 17. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 18. Accidental childhood iron poisoning: a problem of marketing and labeling.
    Krenzelok EP; Hoff JV
    Pediatrics; 1979 Apr; 63(4):591-6. PubMed ID: 440869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 20. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.